tiprankstipranks
Ibio Inc (IBIO)
NASDAQ:IBIO
US Market
IBIO
Ibio
RESEARCH TOOLSreports

Ibio (IBIO) Stock News & Sentiment

2,299 Followers
Validating iBio’s Antibody Platform: Buy Rating Driven by IBIO-600’s Differentiated Obesity Profile and Long-Acting Myostatin Inhibition
Premium
Ratings
Validating iBio’s Antibody Platform: Buy Rating Driven by IBIO-600’s Differentiated Obesity Profile and Long-Acting Myostatin Inhibition
22h ago
IBIO
iBio Advances to Clinical Stage With IBIO-600 Trial
Premium
Company Announcements
iBio Advances to Clinical Stage With IBIO-600 Trial
1d ago
8K
IBIO
Insiders Rock Asana, Ibio, Redwire, AFLAC, Sibanye Stillwater
Premium
Weekend Updates
Insiders Rock Asana, Ibio, Redwire, AFLAC, Sibanye Stillwater
12d ago
AFL
RDW
iBio (IBIO-610): Validated Activin E Mechanism, Strategic Trial Positioning, and Attractive Risk-Reward Support a Buy Rating
Premium
Ratings
iBio (IBIO-610): Validated Activin E Mechanism, Strategic Trial Positioning, and Attractive Risk-Reward Support a Buy Rating
14d ago
IBIO
Buy Rating on iBio Driven by Differentiated Activin-Targeting Antibody and Large PH-HFpEF Market Opportunity
Premium
Ratings
Buy Rating on iBio Driven by Differentiated Activin-Targeting Antibody and Large PH-HFpEF Market Opportunity
22d ago
IBIO
Buy Rating on iBio Driven by Promising IBIO-610 Obesity Data and Favorable Risk-Reward Profile
Premium
Ratings
Buy Rating on iBio Driven by Promising IBIO-610 Obesity Data and Favorable Risk-Reward Profile
1M ago
IBIO
iBio Highlights IBIO-610 Obesity and Cardiometabolic Potential
Premium
Company Announcements
iBio Highlights IBIO-610 Obesity and Cardiometabolic Potential
1M ago
8K
IBIO
More IBIO News >

IBIO News on the Web

iBio Advances to Clinical Stage With IBIO-600 Trial
TipRanks News
Bearish
iBio receives regulatory clearance to initiate IBIO-600 trial in Australia
TipRanks News
Bullish
Biotech Alert: Searches spiking for these stocks today
TipRanks News
Neutral
Insiders Rock Asana, Ibio, Redwire, AFLAC, Sibanye Stillwater
TipRanks News
Bullish
Top Ibio Insider Quietly Ups Stake in Bold New Bet
TipRanks News
Neutral
Insider Buying: Marc Banjak Acquires Additional Shares of iBio Inc (IBIO)
GuruFocus News
Neutral
iBio (IBIO-610): Validated Activin E Mechanism, Strategic Trial Positioning, and Attractive Risk-Reward Support a Buy Rating
TipRanks News
Bullish
Top Ibio Insiders Quietly Load Up on Shares in Bold Confidence Move
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
IBIO
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IBIO’s Media Buzz Sentiment?
1 articles about IBIO were published this week. In an average week, 3.25 articles are published.
    What is IBIO’s weekly average amount of articles?
    In an average week, 3.25 articles about IBIO are published.
      What is IBIO’s News Sentiment?
      100% of articles about IBIO were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        VCELVericel
        NBIXNeurocrine
        ANGOAngioDynamics
        ORGOOrganogenesis Holdings
        AORTArtivion
        Showing the stocks with the most bullish news sentiment over the past week